Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Major EO, Yousry TA, Clifford DB. Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol. 2018;17(5):467–80.
2. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425–37.
3. Chery GS, Palmer SM, Snyder LD, Todd JL, Wolfe C. Brincidofovir in progressive multifocal leukoencephalopathy after lung transplant. Am J Respir Crit Care Med. 2015;191:A1432.
4. Eckert S, Weinstock-Guttman B, Kolb C, Hojnacki D (2018) Treatment of natalizumab induced PML with cidofovir or CMX001 (brincidofovir) and mirtazapine. Neurology 90:P5–380
5. Hall ODH, Dafni RD, Patricia P, Wetherill EW, McArthur CA, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with HIV infection. N Engl J Med. 1998;338:1345–51.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献